12/06/2024
4:00 PM | Omega Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/05/2024
3:05 PM | Mehrotra Ravi (Reporting)
Omega Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
11/26/2024
5:27 PM | Nelson Jennifer Ann (Reporting)
Omega Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
11/26/2024
5:31 PM | Nelson Jennifer Ann (Reporting)
Omega Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/15/2024
5:09 PM | Certel Kaan (Reporting)
Omega Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/04/2024
4:10 PM | Omega Therapeutics (Issuer)
Rosiello Robert L. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/04/2024
4:00 PM | Omega Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
|
10/04/2024
4:01 PM | Omega Therapeutics (Issuer)
Rosiello Robert L. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
08/30/2024
3:01 PM | Omega Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/06/2024
6:02 AM | Omega Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/06/2024
6:03 AM | Omega Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
06/21/2024
3:15 PM | Kender Richard N (Reporting)
Omega Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
05/31/2024
3:49 PM | Chan Barbara Y (Reporting)
Omega Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
05/31/2024
3:50 PM | Certel Kaan (Reporting)
Omega Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
05/31/2024
3:57 PM | Certel Kaan (Reporting)
Omega Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/30/2024
4:04 PM | Omega Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/30/2024
4:10 PM | Omega Therapeutics (Filer)
| Form 8-K/A | |
05/06/2024
6:04 AM | Omega Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/06/2024
6:06 AM | Omega Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/29/2024
6:15 AM | Omega Therapeutics (Filer)
| Form DEFA14A | |
04/29/2024
6:00 AM | Omega Therapeutics (Filer)
| Form DEF 14A | |
04/16/2024
3:20 PM | Omega Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/12/2024
11:03 AM | Omega Therapeutics (Subject)
| Form SC 13G/A | |
02/09/2024
3:17 PM | HarbourVest Partners L.P. (Filed by)
Omega Therapeutics (Subject)
| Form SC 13G/A | |
02/09/2024
8:28 AM | FMR LLC (Filed by)
Omega Therapeutics (Subject)
| Form SC 13G/A | |
Free OMGA Stock Alerts